|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||85.11 - 86.11|
|52 Week Range||63.80 - 87.49|
|PE Ratio (TTM)||66.50|
|Dividend & Yield||1.24 (1.46%)|
|1y Target Est||N/A|
Stryker's (SYK) diverse product portfolio alongside acquisition-driven strategy would continue to boost growth prospects. However, competition in the Chinese market raise concern.
IDEXX Laboratories (IDXX) rides high on strength across all segments, with significant contributions from the Companion Animal Group business. Moreover, a raised guidance buoys optimism.
Align Technology (ALGN) continues to ride high on robust growth in the Invisalign space.